Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to...
Stay updated with breaking news from Alkermes Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to...
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it has entered into a definitive agreement to sell its development and manufacturing facility...
(BPT) - Sponsored by Alkermes, Inc.
(BPT) - Sponsored by Alkermes, Inc.
The global opioid use disorder treatment market size is expected to attain an impressive valuation of US$ 3.07 billion in 2023 and is projected to reach US$ 8.4 billion by 2033, expanding at a CAGR of 10.5% during the forecast period. The drug abuse treatment providers and manufacturers primarily focus on creating a...